Encompass Health/$EHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Encompass Health
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Ticker
$EHC
Sector
Primary listing
NYSE
Employees
26,272
Headquarters
Website
Encompass Health Metrics
BasicAdvanced
$11B
19.30
$5.54
0.56
$0.72
0.71%
Price and volume
Market cap
$11B
Beta
0.56
52-week high
$127.99
52-week low
$92.53
Average daily volume
1.4M
Dividend rate
$0.72
Financial strength
Current ratio
1.083
Quick ratio
0.827
Long term debt to equity
80.707
Total debt to equity
82.847
Dividend payout ratio (TTM)
12.56%
Interest coverage (TTM)
8.55%
Profitability
EBITDA (TTM)
1,381
Gross margin (TTM)
43.22%
Net profit margin (TTM)
9.54%
Operating margin (TTM)
17.74%
Effective tax rate (TTM)
20.24%
Revenue per employee (TTM)
$230,000
Management effectiveness
Return on assets (TTM)
9.66%
Return on equity (TTM)
24.82%
Valuation
Price to earnings (TTM)
19.304
Price to revenue (TTM)
1.811
Price to book
4.39
Price to tangible book (TTM)
13.17
Price to free cash flow (TTM)
24.473
Free cash flow yield (TTM)
4.09%
Free cash flow per share (TTM)
4.37
Dividend yield (TTM)
0.67%
Forward dividend yield
0.71%
Growth
Revenue change (TTM)
10.46%
Earnings per share change (TTM)
24.25%
3-year revenue growth (CAGR)
10.92%
10-year revenue growth (CAGR)
6.66%
3-year earnings per share growth (CAGR)
27.09%
10-year earnings per share growth (CAGR)
11.26%
3-year dividend per share growth (CAGR)
-5.75%
10-year dividend per share growth (CAGR)
-1.99%
What the Analysts think about Encompass Health
Analyst ratings (Buy, Hold, Sell) for Encompass Health stock.
Encompass Health Financial Performance
Revenues and expenses
Encompass Health Earnings Performance
Company profitability
Encompass Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Encompass Health stock?
Encompass Health (EHC) has a market cap of $11B as of March 10, 2026.
What is the P/E ratio for Encompass Health stock?
The price to earnings (P/E) ratio for Encompass Health (EHC) stock is 19.3 as of March 10, 2026.
Does Encompass Health stock pay dividends?
Yes, the Encompass Health (EHC) stock pays dividends to shareholders. As of March 10, 2026, the dividend rate is $0.72 and the yield is 0.71%. Encompass Health has a payout ratio of 12.56% on a trailing twelve-month basis.
When is the next Encompass Health dividend payment date?
The next Encompass Health (EHC) dividend payment is scheduled for April 15, 2026.
What is the beta indicator for Encompass Health?
Encompass Health (EHC) has a beta rating of 0.56. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.